Evidence map›Paper›PMID 41219131›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2025

Chemogenetic Inhibition and Optogenetic Depotentiation of the Prelimbic Cortex to Paraventricular Thalamus Pathway Attenuate Abstinence-Induced Plasticity and Heroin Seeking in Rats.

Allison L Jensen, Cody A Lis, Sydney N Ackerman, Thomas K Willard, Christopher Anthony T Kipp, Maya A Nash, Nathaneal J Huston, Giuseppe Giannotti

Abstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Allison L JensenDepartment of Integrative Physiology and Neuroscience, Washington State University, Pullman, Washington 99164.
Cody A LisDepartment of Integrative Physiology and Neuroscience, Washington State University, Pullman, Washington 99164.
Sydney N AckermanDepartment of Integrative Physiology and Neuroscience, Washington State University, Pullman, Washington 99164.
Thomas K WillardDepartment of Integrative Physiology and Neuroscience, Washington State University, Pullman, Washington 99164.
Christopher Anthony T KippDepartment of Integrative Physiology and Neuroscience, Washington State University, Pullman, Washington 99164.
Maya A NashDepartment of Integrative Physiology and Neuroscience, Washington State University, Pullman, Washington 99164.
Nathaneal J HustonDepartment of Integrative Physiology and Neuroscience, Washington State University, Pullman, Washington 99164.
Giuseppe GiannottiDepartment of Integrative Physiology and Neuroscience, Washington State University, Pullman, Washington 99164 giuseppe.giannotti@wsu.edu.ORCID 0000-0003-0629-4882

Funding

Paraventricular thalamic control of opioid withdrawal and relapseR00DA048974 · NIDA · WASHINGTON STATE UNIVERSITY · PI GIANNOTTI, GIUSEPPE · 2023 to 2025
$746k
NIDA NIH HHS R00 DA048974
6 · The paper itself

Abstract

Opioid use disorder (OUD) is characterized by high relapse rates, underscoring an urgent need to identify neurobiological mechanisms of opioid seeking. The paraventricular thalamus (PVT) is a key brain region implicated in drug seeking in humans and rodents. While the role of its downstream targets is beginning to be clarified, the upstream inputs that regulate PVT activity during opioid seeking remain poorly understood. The prelimbic cortex (PL) provides substantial excitatory input to the PVT and has a well-established role in cue-guided behaviors and drug seeking. However, the contribution of the PL → PVT pathway to heroin seeking is yet to be elucidated. To address this knowledge gap, we trained male and female rats to self-administer heroin for 12 d and then used a pathway-specific chemogenetic approach to transiently inhibit PL → PVT projections during a cued heroin seeking test following 14 d of abstinence. We found that chemogenetic inhibition of this pathway significantly reduced heroin seeking. We next examined synaptic plasticity at PL → PVT synapses ex vivo on withdrawal day 14 and found that abstinence from heroin self-administration induced an increase in AMPA/NMDA ratio compared with saline controls. Importantly, the increase in synaptic strength was normalized by applying an ex vivo optogenetic long-term depression (LTD) protocol. Finally, we applied the same optogenetic LTD protocol in vivo immediately before the cued seeking test and found that depotentiation of PL → PVT synaptic activity significantly reduced heroin seeking. These findings identify PL → PVT inputs as key drivers of heroin seeking and demonstrate that weakening this pathway reduces opioid seeking.

Indexed as

Drug-Seeking BehaviorHeroinHeroin DependenceLong-Term Synaptic DepressionMidline Thalamic NucleiNeuronal PlasticityPrefrontal CortexAnimalsChemogeneticsFemaleMaleNeural PathwaysOptogeneticsRatsRats, Sprague-DawleySelf AdministrationHeroinchemogeneticsheroinoptogeneticsprelimbicrelapsethalamus

Identifiers

PMID41219131
PMCPMC12696633

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.